Chronic granulomatous disease: towards gene therapy.

Article


Thrasher, A., Segal, A. and Casimir, C. 1993. Chronic granulomatous disease: towards gene therapy. Immunodeficiency. 4 (1-4), pp. 327-33.
TypeArticle
TitleChronic granulomatous disease: towards gene therapy.
AuthorsThrasher, A., Segal, A. and Casimir, C.
Abstract

Failure of a superoxide generating system, the NADPH oxidase, present in neutrophils and other phagocytes gives rise to chronic granulomatous disease (CGD), a group of single gene inherited disorders all characterised by an extreme susceptibility to pyogenic infection, with potentially fatal consequences. About 30% of CGD cases are due to an autosomally inherited deficiency of a 47 kDa cytoplasmic component of the oxidase (p47-phox). Epstein-Barr virus (EBV) immortalised B-lymphocyte lines established from these CGD patients also express this NADPH oxidase defect and consequently are rendered incapable of generating superoxide on stimulation. We have utilised a p47-phox-deficient EBV-transformed B cell line as a recipient for retroviral transfer of a functional p47-phox cDNA. The presence and activity of the retrovirally encoded p47-phox in the transduced cells is demonstrated and we show that this restores their capacity to generate superoxide.

Research GroupMolecular Biology group
LanguageEnglish
PublisherHarwood Academic Publishers
JournalImmunodeficiency
ISSN1067-795X
Publication dates
Print1993
Publication process dates
Deposited02 Dec 2009
Output statusPublished
Permalink -

https://repository.mdx.ac.uk/item/81z4w

  • 27
    total views
  • 0
    total downloads
  • 5
    views this month
  • 0
    downloads this month

Export as